Persisting long-COVID-19 syndrome

Česká verzia

Authors: Andrej Dukát ¹; František Sándor ²; Peter Gavorník ³; Juraj Payer ¹
Authors place of work: V. interná klinika LF UK a UNB, Nemocnica Ružinov, Bratislava ¹; Klinika pneumológie a ftizeológie LF UK a UNB, Nemocnica Ružinov, Bratislava ²; Angiologická sekcia Slovenskej lekárskej komory (AS SLK) ³
Published in the journal: Forum Diab 2022; 11(1): 43-48
Category:

Summary

Infection caused by new SARS-CoV-2 syndrome brought of problems, scientific, economical, and in societies in all countries in the world. Ongoing disease is followed by several phases, depending on new virus mutations. For the clinical practice it is of importance for either non-vaccinated and as well for vaccinated persons. Long-COVID syndrome represents still open problem in current medicine.

Keywords:

diabetes mellitus – SARS-CoV-2 – long-COVID syndrome

Zdroje

1. Harding JL, Pavkov ME, Magliano DJ et al. Global trends in diabetes complications: a review of current evidence. Diabetologia 2019; 62(1): 3–16. Dostupné z DOI: <http://dx.doi.org/10.1007/s00125–018–4711–2>.
2. Wu J, Zhang J, Sun X et al. Influence of diabetes mellitus on severity and fatality of SARS-CoV-2 (Covid-19) infection. Diabetes Obes Metab 2020; 22(10):1907–1914. Dostupné z DOI: <http://dx.doi.org/10.1111/dom.14105>.
3. Huang C, Wang Y, Li X et al. Clinical features of patients infected with novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497–506. Dostupné z DOI: <http://dx.doi.org/10.1016/S0140–6736(20)30183–5>.
4. Wang B, Li R, Lu Z et al. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging 2020; 12(7): 6049–6057. Dostupné z DOI: <http://dx.doi.org/10.18632/aging.103000>.
5. Wilson FP. How Bad Can Myocarditis Be After COVID Vaccination? Medscape Dec 6, 2021. Dostupné z WWW: <www.medscape.com>.
6. Nägele MP. Endothelial dysfunction in Covid-19: Current findings and therapeutic implications. Atherosclerosis 2020; 314: 58–62. Dostupné z DOI: <http://doi/10.1016/j.atherosclerosis.2020.10.014>.
7. Morris SB, Noah G, Schwartz NG et al. Case series of multisystem inflammatory syndrome in adults associated with SARSCoV-2 infection – United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep 2020; (40): 1450–1456. Dostupné z DOI: <http://dx.doi.org/10.15585/mmwr.mm6940e1>.
8. Bonow RO, Braunwald E. The Evidence Supporting Cardiovascular Guidelines. Is There Evidence of Progress in the Last Decade? JAMA 2019; 321(11): 1053–1054. Dostupné z DOI: <http://dx.doi.org/10.1001/jama.2019.2018>.
9. Sabel BA, Zhou W, Huber F et al. Non-invasive brain microcurrent stimulation therapy of long-COVID-19 reduces vascular dysregulation and improves visual and cognitive impairment. Restorat Neurol Neurosci 2021; 39(6): 393–408. Dostupné z DOI: <http://dx.doi,org/10.3233/RNN-211249>.
10. Dubin JM, Bennett NE, Halpern JA. The Adverse Impact of COVID-19 on Men´s Health. Curr Opin 2022; 32(2): 146–151. Dostupné z DOI: <http://dx.doi.org/10.1097/MOU.0000000000000966>.
11. Hirose R, Miyazaki H, Bandou R et al. Stability of SARS-CoV-2 and influenza virus varies across different paper types. J Infect Chemother 2022;2 8(2): 252–256. Dostupné z DOI: <http://doi: 10.1016/j.jiac.2021.11.006>.
12. Heesakkers H, van der Hoeven JG, Corsten S et al. Clinical Outcomes Among Patients With 1-year Survival Following Intensive Care Unit Treatment for COVID-19. JAMA 2022; 327(6): 559–565. Dostupné z DOI: <http://dx.doi.org/10.1001/jama.2022.0040>.
13. Chang WT, Toh HS, Liao CT et al. Cardiac Involvement of COVID-19: A Comprehensive Review. Am J Med Sci 2021; 361(1): 14–22. Dostupné z DOI: <http://doi:10.1016/j.amjms.2020.10.002>.